Stakes

Synopsis : In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business…

Summary : The company will invest up ₹6 crore for the 33% stake in the target firm Cipla on Wednesday announced that…

Synopsis- Alembic said it has acquired preferred stock in RIGImmune amounting to a 19.97% post-money stake in the first closing of the…